SIRT3 and sarcopenia: Future investigations should aim to elucidate the mechanisms by which SIRT3 interfaces with tissue-specific immune circuits and determine whether pharmacologic activation of SIRT3 can confer resilience against aging-related inflammatory disorders such as atherosclerosis, neuroinflammation, and sarcopenia.